ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,115Medicare Part D Prescriptions Filled, Including Refills

Rank: 226 out of 1456

$1.21M Total Retail Price of All Prescriptions

Rank: 69 out of 1456

572 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 572 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 13,534 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 859 832 1 2
LOVAZA 729 712 2 162
NEXIUM 655 627 3 23
AMLODIPINE BESYLATE 405 373 4 1
LIDODERM 390 383 5 166
CELEBREX 326 326 6 88
TAMSULOSIN HCL 321 320 7 34
METFORMIN HCL ER 315 308 8 54
AZITHROMYCIN 293 286 9 44
ALENDRONATE SODIUM 288 261 10 36
PREDNISONE 266 253 11 42
DIOVAN HCT 261 251 12 59
LEVOTHYROXINE SODIUM 203 199 13 4
LOSARTAN-HYDROCHLOROTHIAZIDE 199 181 14 41
RANITIDINE HCL 186 174 15 27
DIOVAN 184 179 16 35
LOSARTAN POTASSIUM 183 176 17 16
METFORMIN HCL 182 168 18 8
LISINOPRIL 171 159 19 3
ATORVASTATIN CALCIUM 155 148 20 11
OMEPRAZOLE 153 146 21 5
HYDROCODONE-ACETAMINOPHEN 150 131 S3 22 6
CLOTRIMAZOLE-BETAMETHASONE 147 143 23 163
GLIMEPIRIDE 144 133 24 33
NAMENDA 143 143 25 38
JANUVIA 140 140 26 68
GABAPENTIN 124 119 27 13
ZOLPIDEM TARTRATE 122 121 28 14
VOLTAREN 118 117 29 214
CEPHALEXIN 113 112 30 123
AVODART 111 111 31 218
CIPROFLOXACIN HCL 109 99 32 58
FINASTERIDE 103 103 33 110
PRAVASTATIN SODIUM 101 94 34 9
CRESTOR 100 99 35 26
CARVEDILOL 98 97 36 20
LANTUS SOLOSTAR 95 86 37 120
BENICAR HCT 94 94 38 160
ATENOLOL 93 90 39 18
GLYBURIDE-METFORMIN HCL 93 91 R 39 119
CREON 92 92 41 296
LYRICA 86 86 42 91
MELOXICAM 86 86 42 30
TRIBENZOR 85 85 44 307
WARFARIN SODIUM 85 81 44 21
TRIAMCINOLONE ACETONIDE 84 84 46 158
PROLIA 83 82 47 438
FLUTICASONE PROPIONATE 82 77 48 28
TRAMADOL HCL 80 74 49 17
METOCLOPRAMIDE HCL 80 76 49 125
TRIAMTERENE-HCTZ 78 74 51 49
ZOSTAVAX 76 64 52 187
ALLOPURINOL 75 73 53 31
SERTRALINE HCL 74 73 54 25
FLUOCINONIDE 73 69 55 314
JANUMET 72 72 56 176
FUROSEMIDE 65 60 57 7
GLIPIZIDE ER 65 65 57 86
LABETALOL HCL 62 62 59 180
EXFORGE 61 61 60 211
BENICAR 60 55 61 130
AMOXICILLIN 60 51 61 112
FAMOTIDINE 60 60 61 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 58 64 24
ATENOLOL-CHLORTHALIDONE 58 57 65 172
MEGESTROL ACETATE 58 58 R 65 179
BETAMETHASONE DIPROPIONATE 57 53 67 341
CLOPIDOGREL 54 53 68 32
JALYN 54 54 68 420
BETAMETHASONE VALERATE 52 50 70 371
LOVASTATIN 52 50 70 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.